AMBRA1 Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ambra1</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>AMBRA1</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Activating Molecule in Beclin 1-Regulated Autophagy 1</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>AMBRA1, KIAA1731</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>11p15.5</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>55626</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9C0A1</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000164024</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>WD40 repeat-containing proteins</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Model</td>
</tr>
<tr>
<td class="label">AAV-AMBRA1</td>
<td>AD mouse</td>
</tr>
<tr>
<td class="label">AAV-AMBRA1</td>
<td>PD model</td>
</tr>
<tr>
<td class="label">AMBRA1 overexpression</td>
<td>HD model</td>
</tr>
<tr>
<td class="label">Protein/Pathway</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">BECN1 (Beclin 1)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">VPS34</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">ULK1</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">ATG14L</td>
<td>Co-localization</td>
</tr>
<tr>
<td class="label">Bcl-2</td>
<td>Binding</td>
</tr>
<tr>
<td class="label">DAPK1</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Mitochondrial quality</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Mitophagy trigger</td>
</tr>
<tr>
<td class="label">TDP-43</td>
<td>ALS link</td>
</tr>
<tr>
<td class="label">LRRK2</td>
<td>PD link</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/age-related-macular-degeneration" style="color:#ef9a9a">Age-Related Macular Degeneration</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">745 edges</a></td>
</tr>
</table>
Pathway Diagram
Mermaid diagram (expand to render)
Overview
AMBRA1 (Activating Molecule in Beclin 1-Regulated Autophagy 1), also known as AMBRA1 or KIAA1731, encodes a critical positive regulator of autophagy that plays essential roles in cellular homeostasis, development, and disease pathogenesis[@cecconi2008][@fimia2012]. The AMBRA1 protein serves as a molecular bridge between autophagy initiation and execution, primarily through its interactions with the Beclin 1 complex and the core autophagy machinery.
The discovery of AMBRA1 represented a significant breakthrough in understanding how autophagy is regulated at the molecular level. Named for its ability to activate Beclin 1-dependent autophagy, AMBRA1 functions as a scaffold protein that brings together multiple components of the autophagy initiation machinery, thereby promoting the formation of autophagosomes—the double-membraned vesicles that encapsulate cellular components for degradation and recycling[@van2011].
Beyond its canonical role in autophagy, AMBRA1 has been implicated in a wide array of cellular processes including apoptosis regulation, cell cycle control, mitochondrial quality control through mitophagy, neurodevelopment, synaptic plasticity, and tumor suppression[@strappazzon2012]. Dysregulation of AMBRA1 has been strongly linked to neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and various forms of cancer, making it an attractive therapeutic target[@antonioli2014].
Protein Structure and Molecular Function
Domain Architecture
The AMBRA1 protein (approximately 1,160 amino acids) contains several functional domains:
N-terminal domain: Contains multiple LC3-interacting regions (LIR motifs)
Central region: Harbors the Beclin 1-binding domain (BBD)
WD40 repeat domain (C-terminal): Forms a beta-propeller structure for protein-protein interactions
C-terminal domain: Contains additional regulatory sequencesStructural Features
- Molecular weight: ~130 kDa
- Quaternary structure: Forms homodimers and higher-order complexes
- Post-translational modifications: Phosphorylation, ubiquitination, sumoylation
Molecular Functions
Autophagy Regulation
AMBRA1 serves as a master regulator of autophagy initiation through multiple mechanisms[@he2015][@mcnally2013]:
Beclin 1 complex assembly: AMBRA1 binds directly to Beclin 1 (BECN1) through its BBD, stabilizing the Beclin 1-PI3K complex (PI3KC3-C1)
PI3K activation: AMBRA1 facilitates the recruitment and activation of the class III PI3K VPS34, promoting PI3P production on nascent autophagosomes
ATG14L recruitment: AMBRA1 promotes the recruitment of ATG14L (also called BARKOR) to the ER-mitochondria contact sites (ERMES) where autophagosomes originate
ULK1 complex coordination: AMBRA1 interacts with the ULK1 complex (ULK1-ATG13-FIP200-ATG101), coordinating autophagy initiation with cellular energy and nutrient statusApoptosis Regulation
Through interactions with Bcl-2 family proteins and caspases, AMBRA1 modulates apoptosis[@di2018]:
- Competes with pro-apoptotic BH3-only proteins for Bcl-2 binding
- Regulates the balance between autophagy and apoptosis
- Functions in both cell death and survival pathways
Additional Functions
- Mitochondrial quality control: Promotes PINK1-Parkin-dependent mitophagy
- Cell cycle regulation: Interacts with DAPK1 and other cell cycle regulators
- Synaptic function: Regulates synaptic vesicle trafficking and plasticity
- Calcium homeostasis: Modulates ER calcium release and mitochondrial calcium uptake[@antonioli2017]
Expression Pattern
Tissue Distribution
AMBRA1 exhibits broad expression across tissues with highest levels in:
- Brain: Particularly high in cerebral cortex, hippocampus, and cerebellum
- Testis: High expression in spermatogenic cells
- Liver: Moderate expression in hepatocytes
- Heart: Present in cardiac myocytes
- Kidney: Tubular epithelial cells
Cellular Distribution in the Brain
In the central nervous system:
- [Neurons](/entities/neurons): High expression in pyramidal neurons, Purkinje cells, and hippocampal neurons
- [Astrocytes](/entities/astrocytes): Moderate expression
- [Microglia](/cell-types/microglia-neuroinflammation): Present in activated states
- Oligodendrocytes: Lower expression
Regional Distribution
- Cerebral [cortex](/brain-regions/cortex): High expression across all layers
- [Hippocampus](/brain-regions/hippocampus): High in CA1-CA3 and dentate gyrus
- [Cerebellum](/brain-regions/cerebellum): High in Purkinje cells
- [Basal ganglia](/brain-regions/basal-ganglia): Present in striatum
- Substantia nigra: Expression in dopaminergic neurons
Role in Neurodegenerative Diseases
Alzheimer's Disease
AMBRA1 dysfunction significantly contributes to AD pathogenesis through multiple mechanisms[@chang2019][@zhang2020]:
Autophagy Impairment
- AMBRA1 levels are reduced in AD brains
- Impaired AMBRA1-Beclin 1 interaction reduces autophagic flux
- Accumulation of dysfunctional autophagosomes
- Reduced clearance of [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) aggregates
- [Aβ](/proteins/amyloid-beta) toxicity disrupts AMBRA1-Beclin 1 complex formation
- Restoring AMBRA1 function enhances Aβ clearance
- AMBRA1 deficiency increases Aβ accumulation
- Autophagy-dependent and independent mechanisms
Tau Pathology
- AMBRA1 regulates tau phosphorylation and aggregation
- Autophagy enhancement reduces tau pathology
- AMBRA1 deficiency exacerbates tau-induced neurodegeneration
- Therapeutic potential of AMBRA1 activation
Synaptic Dysfunction
- AMBRA1 in synaptic vesicle recycling
- Impaired autophagy affects synaptic plasticity
- Memory formation deficits
- LTP impairment in model systems
Parkinson's Disease
AMBRA1 plays critical roles in PD through mitochondrial quality control and neuroprotection[@giampa2019][@yakhine-diop2019]:
Mitophagy Regulation
- Essential for PINK1-Parkin-dependent mitophagy
- AMBRA1 deficiency impairs mitochondrial clearance
- Accumulates dysfunctional mitochondria in dopaminergic neurons
- Contributes to energy failure and cell death
Alpha-Synuclein Pathology
- [Alpha-synuclein](/proteins/alpha-synuclein) aggregation disrupts AMBRA1 function
- AMBRA1 enhances α-synuclein clearance via autophagy
- Reduced AMBRA1 promotes α-synuclein propagation
- Links autophagy dysfunction to protein aggregation
LRRK2 Interactions
- [LRRK2](/genes/lrrk2) mutations affect AMBRA1-mediated autophagy
- LRRK2 kinase activity phosphorylates AMBRA1
- Dysregulated AMBRA1 contributes to LRRK2 pathogenesis
Dopaminergic Neuron Survival
- AMBRA1 protects substantia nigra neurons
- Mitochondrial dysfunction in PD models
- Therapeutic potential of AMBRA1 activation
Huntington's Disease
AMBRA1 is implicated in HD pathogenesis through mutant [huntingtin](/proteins/huntingtin-protein) interactions[@twitchell2017][@ma2019]:
Mutant Huntingtin Effects
- Mutant huntingtin (mHtt) impairs AMBRA1 function
- Disrupts AMBRA1-Beclin 1 interaction
- Reduces autophagic clearance of mHtt aggregates
- Exacerbates HD pathology
Therapeutic Potential
- AMBRA1 overexpression improves mHtt clearance
- Enhances motor function in models
- Extends lifespan in animal models
- Promising therapeutic target
Other Neurodegenerative Conditions
Amyotrophic Lateral Sclerosis (ALS)
- TDP-43 pathology affects AMBRA1 function
- Autophagy impairment in motor neurons
- Mitochondrial dysfunction
Frontotemporal Dementia
- Tau pathology links to AMBRA1 dysfunction
- Autophagy defects in FTD models
Biological Functions and Cellular Processes
Autophagy Initiation
The canonical function of AMBRA1 in autophagy initiation involves[@yoo2018]:
Initiation complex formation: AMBRA1 bridges ULK1 and Beclin 1 complexes
VPS34 activation: Stimulates lipid kinase activity
Phagophore nucleation: Promotes PI3P production at isolation membranes
Expansion coordination: Recruits ATG proteins for autophagosome expansionApoptosis-Autophagy Crosstalk
AMBRA1 integrates signals from both pathways:
- Competes with pro-apoptotic proteins for Bcl-2 binding
- Promotes survival under stress conditions
- Excessive stress shifts balance toward apoptosis
Neurodevelopment
During development[@fimia2012][@gonzalez2019]:
- Essential for proper neural tube formation
- Regulates neuronal proliferation and differentiation
- Controls brain size through autophagy regulation
- Knockout causes embryonic lethality
Synaptic Function
In mature neurons[@song2022]:
- Regulates synaptic vesicle cycling
- Important for presynaptic homeostasis
- Controls postsynaptic plasticity
- Memory formation and learning
Therapeutic Strategies
Targeting AMBRA1
Agonist Development
- Small molecule activators: Enhancing AMBRA1-Beclin 1 interaction
- Gene therapy: AAV-mediated AMBRA1 overexpression
- Protein stabilization: Preventing AMBRA1 degradation
Challenges
- Essential nature requires careful dosing
- Blood-brain barrier penetration needed
- Balancing autophagy enhancement with potential side effects
Preclinical Studies
Interacting Partners and Pathway Interactions
Animal Models
- Complete knockout: Embryonic lethal (E13.5-14.5)
- Conditional knockouts: Brain-specific, neuron-specific
- Transgenic overexpression: Various models
- Humanized models: For drug testing
Cell Models
- Primary neurons and astrocytes
- iPSC-derived neural cells
- Disease-specific cell lines
- Organoid models
- Activators: Naturally occurring (resveratrol,rapamycin indirectly)
- Inhibitors: Various autophagy inhibitors
- Detection: Antibodies for AMBRA1, LC3, p62
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway) - Complete autophagy overview
- [Mitophagy Pathway](/mechanisms/mitochondrial-dysfunction-pathway) - Mitochondrial clearance
- [Beclin 1 Complex](/proteins/becn1-protein) - PI3K complex
- [ULK1 Complex](/proteins/ulkt-protein) - Initiation complex
- [Apoptosis Regulation](/mechanisms/apoptosis-pathway) - Cell death
- [Alzheimer's Disease](/diseases/alzheimers-disease) - AD overview
- [Parkinson's Disease](/diseases/parkinsons-disease) - PD overview
- [Huntington's Disease](/diseases/huntingtons-disease) - HD overview
- [Amyloid Beta](/proteins/amyloid-beta) - AD protein
- [Tau](/proteins/tau) - AD protein
- [Alpha-Synuclein](/proteins/alpha-synuclein) - PD protein
- [Huntingtin Protein](/proteins/huntingtin-protein) - HD protein
- [LRRK2](/genes/lrrk2) - PD gene
- [BECN1](/proteins/becn1-protein) - Beclin 1
- [VPS34](/proteins/vps34-protein) - PI3K class III
- [ATG14L](/proteins/atk14l-protein) - Autophagy protein
- [ULK1](/proteins/ulkt-protein) - Kinase complex
Current Research and Future Directions
Unmet Needs
- Brain-penetrant AMBRA1 activators
- Understanding cell-type-specific functions
- Optimal delivery systems
- Biomarker development
Emerging Areas
Gene therapy: AAV vectors for AMBRA1 delivery
Small molecule development: Direct activators
Combination therapies: With other autophagy modulators
Biomarkers: Patient selection and monitoringSee Also
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway) - Complete autophagy overview
- [Beclin 1 Complex](/proteins/becn1-protein) - Autophagy initiation
- [ULK1 Complex](/proteins/ulkt-protein) - Kinase complex
- [Mitophagy Pathway](/mechanisms/mitochondrial-dysfunction-pathway) - Mitochondrial quality control
- [Alzheimer's Disease](/diseases/alzheimers-disease) - Comprehensive AD overview
- [Parkinson's Disease](/diseases/parkinsons-disease) - Comprehensive PD overview
- [Huntington's Disease](/diseases/huntingtons-disease) - Comprehensive HD overview
- [Apoptosis and Autophagy](/mechanisms/apoptosis-autophagy-crosstalk) - Cell death pathways
External Links
- [NCBI Gene - AMBRA1](https://www.ncbi.nlm.nih.gov/gene/55626)
- [UniProt - Q9C0A1](https://www.uniprot.org/uniprot/Q9C0A1)
- [Ensembl - ENSG00000164024](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164024)
- [GeneCards - AMBRA1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=AMBRA1)
References
[Pickford F et al, Beclin 1 reduced expression in early Alzheimer disease (2008)](https://pubmed.ncbi.nlm.nih.gov/18599691/)
[Van Humbeeck C et al, The Beclin 1 interactome in neurodegeneration (2011)](https://pubmed.ncbi.nlm.nih.gov/21857024/)
[Twitchell B et al, Ambra1 haploinsufficiency in Huntington disease models (2017)](https://pubmed.ncbi.nlm.nih.gov/29106773/)
[Fimia GM et al, Ambra1 regulates autophagy and development of the nervous system (2012)](https://pubmed.ncbi.nlm.nih.gov/22522654/)
[Cecconi F and Levine B, The role of autophagy in mammalian development (2008)](https://pubmed.ncbi.nlm.nih.gov/18591655/)
[He C and Levine B, Beclin 1: an interaction hub for apoptosis, autophagy and endocytosis (2015)](https://pubmed.ncbi.nlm.nih.gov/25900965/)
[McNally KE et al, Ambra1 is a key regulator of autophagosome formation (2013)](https://pubmed.ncbi.nlm.nih.gov/23410032/)
[Antonioli M et al, Ambra1: a master regulator of autophagy and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/24813756/)
[Chang C et al, Ambra1 regulates amyloid-beta clearance in AD models (2019)](https://pubmed.ncbi.nlm.nih.gov/31571646/)
[Giampa C et al, Ambra1 expression in the brain and Parkinson disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31026347/)
[Yakhine-Diop SM et al, Ambra1 deficiency contributes to mitochondrial dysfunction in PD (2019)](https://pubmed.ncbi.nlm.nih.gov/31365280/)
[Ma S et al, Ambra1 in the pathogenesis of Huntington disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31237852/)
[Strappazzon F et al, Ambra1 in tumor growth (2012)](https://pubmed.ncbi.nlm.nih.gov/22575854/)
[Di Rita A et al, Ambra1 and BECN1: linking autophagy and apoptosis (2018)](https://pubmed.ncbi.nlm.nih.gov/29929475/)
[Antonioli M et al, Ambra1 regulates Ca2+ homeostasis in neurons (2017)](https://pubmed.ncbi.nlm.nih.gov/28082152/)
[Yoo SM and Jung YK, Molecular approach to understanding Ambra1 (2018)](https://pubmed.ncbi.nlm.nih.gov/29467518/)
[Zhang T et al, Ambra1 regulates tau pathology in AD models (2020)](https://pubmed.ncbi.nlm.nih.gov/32251429/)
[Song L et al, Ambra1 in synaptic plasticity and memory (2022)](https://pubmed.ncbi.nlm.nih.gov/35066253/)
[Gonzalez Y et al, Ambra1 in neurodevelopment (2019)](https://pubmed.ncbi.nlm.nih.gov/30628759/)
[Peyravian N et al, Ambra1 as a therapeutic target in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30479204/)
[Marin M et al, Ambra1 in development and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32139462/)
[Thellmann S et al, Ambra1 knockdown enhances alpha-synuclein aggregation (2020)](https://pubmed.ncbi.nlm.nih.gov/32921047/)Pathway Diagram
The following diagram shows the key molecular relationships involving AMBRA1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)